Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, May 22, 2013
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Program for Breakthrough Biomedical Research to Celebrate 15 Years
A program that fosters basic science projects of potentially high impact is celebrating 15 years of discovery at UC San Francisco.
UCSF Scientists Use Human Stem Cells to Generate Immune System in Mice
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
Team Successfully Converts Human Skin Cells into Embryonic Stem Cells
The breakthrough marks the first time human stem cells have been produced via nuclear transfer and follows several unsuccessful attempts by research groups worldwide.
Nobel Prize Rockets Stem Cell Program to New Heights
Shinya Yamanaka's Feat Brings fresh attention to promise of regeneration medicine.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
Companies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
Stem Cells Show Promise for Treating Rare Nerve Disease
Scientists have used iPS cells to advance disease-in-a-dish modeling of a rare genetic disorder, ataxia telangiectasia (A-T).
Two MIT Professors Named Howard Hughes Medical Institute Investigators
Peter Reddien and Aviv Regev are among 27 top biomedical scientists selected nationwide.
Cell Therapy Promise Highlighted at UCSF Symposium
Old-line pharmaceutical companies and maturing biotech businesses both are graybeards compared to newer ventures focused on cell therapy.
Researchers Chart Epigenomics of Stem Cells That Mimic Early Human Development
Collaborative study will help overcome hurdles to using stem cells to treat diseases and injuries.
NYSCF Scientists Create Personalized Bone Substitutes from Skin Cells
For treatment of large bone defects and traumatic injuries.

Pan-European Legal Trends in Stem Cells Research and Therapy
Philippa Montgomerie, Partner, DLA Piper, speaking at Stem Cells Europe 2010.

Validation of Adherent, Non-immortalized Mouse and Human Neural Stem Cell Technology for Scaled-up Automated Culture, Assay Development and Compound Screening
Donna McLaren, Head of Development, Stem Cell Sciences UK, speaking at Stem Cells Europe 2010.

Comprehensive Workflow Solutions for Cellular Analysis and Stem Cell Research
John McDonald, Cellular Analysis Technical Specialist, Roche, speaking at Stem Cells Europe 2010.

Stem Cell Therapies - How to Get to Market
Joyce Frey-Vasconcells, Director, PharmaNet Development Group, speaking at Stem Cells Europe 2010.

Rem2 GTPase is a Critical Mediator of the Pluripotency/Differentiation Switch in the Developing Embryo by Regulating the Cell Cycle and Apoptosis
Michael Edel, Carlos III Principle Investigator, Center of Regenerative Medicine, speaking at Stem Cells Europe 2010.

Mesenchymal Stem Cells From Wharton’s Jelly of the Umbilical Cord: An Exciting New Cell Source for Musculoskeletal Tissue Regeneration?
Michael Detamore, Associate Professor, University of Kansas, speaking at Stem Cells Europe 2010.

Homogeneous, Bioluminescent Assays for the Mechanistic Assessment of Toxicity of iPS Cardiomyocytes
Mie Cong, R&D Research Manager, Promega, speaking at Stem Cells Europe 2010.

P38MAPK Controls the Early Commitment of Embryonic Stem Cells Towards Mesodermal Lineages
Bernard Binetruy, Researcher, Inserm, speaking at Stem Cells Europe 2010.

Stem Cell Recruitment as a Strategy for Tissue Repair
Daniel Peterson, Executive Director, Rosalind Franklin University of Medicine and Science, Speaking at Stem Cells World Congress 2010.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 109
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net